4.9 Capital investment in
primary care.
4.9a Could the Department please provide
data on all grants, public loans and capital receipts used to
fund or finance primary care facilities since 1997. Data should
be provided on an annual basis from 1997 and by health authority.
4.9b Could the Department please provide
a list of primary care premises which have signed or in the process
of signing up for the use of PFI, together with their total capital
cost, the length of contract, the annual unitary charge and availability
fee and FM fee. Where projects are bundled with non-NHS facilities,
could they also provide details of the other income streams eg
from commercial and retail, local authority.
4.9c Could the Department please provide
a full account of the revenue implications of using private finance
for all primary care schemes annually for the next ten years.
4.9d Could the Department please provide
an account of all loans outstanding on primary care premises and
the ownership of these premises.
4.9e Could the Department please provide
a list of the top twenty companies involved in primary care PPPs,
together with the value of their asset base, their turnover and
profits, the value of NHS contracts signed, the loans outstanding
and the NHS revenue streams.
4.9f Could the Department please provide
an account of the value of NHS primary care facilities, the total
value of primary care estate and the backlog in maintenance and
repairs on primary care facilities.
4.9a Could the Department please provide
data on all grants, public loans and capital receipts used to
fund or finance primary care facilities since 1997. Data should
be provided on an annual basis from 1997 and by health authority.
1. Information is not available by Health
Authority
Transfer of HCHS capital for Revenue Allocations
for 1996-97 to 2001-02
|
| | £m
|
|
| 1996-97 | 24
|
| 1997-98 | 25
|
| 1998-99 | 26
|
| 1999-00 | 26
|
| 2000-01 | 27
|
| 2001-02 | N/A
|
|
4.9b Could the Department please provide a list of
primary care premises which have signed or in the process of signing
up for the use of PFI, together with their total capital cost,
the length of contract, the annual unitary charge and availability
fee and FM fee. Where projects are bundled with non-NHS facilities,
could they also provide details of the other income streams eg
from commercial and retail, local authority.
2. PFI is not currently used for the provision of primary
care premises in the NHS.
4.9c Could the Department please provide a full account
of the revenue implications of using private finance for all primary
care schemes annually for the next ten years.
3. All current support takes place under existing rental
reimbursement schemes (eg notional, actual); information on the
costs and trends is given in the answer to question 4.3c.
4. The revenue costs and future revenue implications
of NHS LIFT schemes can be provided in future years to the Health
Select Committee when contracts have been signed under this initiative.
4.9d Could the Department please provide an account
of all loans outstanding on primary care premises and the ownership
of these premises.
5. The answer to this is the same as to question 4.3f.
The vast majority of premises are funded through private capital
borrowed from a range of specialist and high street financial
institutions and banks. Details of outstanding loans are considered
commercially sensitive and are not available.
6. In addition, NHS LIFT is a new initiative for which
contracts have yet to be signed.
4.9e Could the Department please provide a list of
the top twenty companies involved in primary care PPPs, together
with the value of their asset base, their turnover and profits,
the value of NHS contracts signed, the loans outstanding and the
NHS revenue streams.
7. As stated in the answer to question 4.3g, a list of
companies is not yet feasible in this maturing sector of the GP
estate.
4.9f Could the Department please provide an account
of the value of NHS primary care facilities, the total value of
primary care estate and the backlog in maintenance and repairs
on primary care facilities.
8. Please see the answer to questions 4.3d and 4.3e and
the attached pie charts.
4.10 Family Health Services Expenditure
on Prescribing
4.10a Could the Department provide information on
total NHS expenditure on pharmaceuticals, including a breakdown
by sector and by generic/branded drugs? Could the Department please
state what data are available on pharmaceuticals in the non primary
care sector, and how they are monitoring drug spending and cost
pressures in the acute hospital and community sectors?
4.10b Could the Department provide information on
(i) total Family Health Services expenditure on prescribing for
each year from 1992-93 to 2000-01, (ii) the average expenditure
per capita, (iii) the total number of items prescribed and average
number per capita, and (iv) the average cost per prescription?
Any commentary which the Department would wish to append would
be welcome, including an assessment of progress in meeting its
stated target of restraining the growth in the drugs bill to sustainable
and affordable limits?
4.10c Could the Department explain the measures being
taken to control NHS expenditure on generic drugs in primary care
following the price increases in 1999-2000?
4.10d What progress has been made in getting the pharmaceutical
industry to reduce drug costs by 4.5 per cent (as agreed in the
PPRS)? Could the Department comment on issues such as volume,
price and substitution? Has the lack of reliable data to monitor
spending led to a breakdown in cost control?
4.10a Could the Department provide information on
total NHS expenditure on pharmaceuticals, including a breakdown
by sector and by generic/branded drugs? Could the Department please
state what data are available on pharmaceuticals in the non primary
care sector, and how they are monitoring drug spending and cost
pressures in the acute hospital and community sectors?
1. Total NHS net expenditure on medicines and listed
appliances in England in 2000-01 was £6,647m. £5,161m
of this total relates to prescriptions dispensed in the community
and £1,486m [DN This figure is provisional as approximately
30 NHS trusts, 3 HAs and 4 PCTs that have not yet sent in their
financial returns and therefore are not included in this figure]
relates to medicines supplied in a secondary care setting.
2. For prescriptions dispensed in the community in England,
a breakdown between branded medicines, generic medicines, dressings
and listed appliances for the financial years 1992-93 to 2000-01
is provided in table 4.10.1. The table shows both the cost (expressed
in terms of net ingredient cost) and the volume (number of prescription
items) for each category. In 2000-01, branded drugs prescribed
represent about 76 per cent of the total net ingredient cost (inc
the cost of dressings and appliances). In 2000-01, the share of
prescription items written generically was 72 per cent, and the
share of prescription items dispensed generically was 52 per cent.
